A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Clinical trial NCT05556265 · TERMINATED

Trial details

NCT number: NCT05556265
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia Areata

Start date: 2022-11-08
Primary completion: 2024-01-06
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.